Evidence map›Paper›PMID 39413281›Full record

ArticleJournal of medicinal chemistry2024

Maximilian A Zierke, Christine Rangger, Kimia Samadikhah, Christoph Kreutz, Andreas M Schmid, Roland Haubner

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Comparison of twoEJNMMI radiopharmacy and chemistry · 2026
    Article
  2. Molecular pharmaceutics · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maximilian A ZierkeDepartment of Nuclear Medicine, Medical University of Innsbruck, Anichstr. 35, 6020 Innsbruck, Austria.ORCID 0000-0001-5667-9831
Christine RanggerDepartment of Nuclear Medicine, Medical University of Innsbruck, Anichstr. 35, 6020 Innsbruck, Austria.
Kimia SamadikhahWerner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Röntgenweg 13, 73076 Tübingen, Germany.
Christoph KreutzInstitute of Organic Chemistry and Center for Molecular Biosciences (CMBI), University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria.ORCID 0000-0002-7018-9326
Andreas M SchmidWerner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Röntgenweg 13, 73076 Tübingen, Germany.
Roland HaubnerDepartment of Nuclear Medicine, Medical University of Innsbruck, Anichstr. 35, 6020 Innsbruck, Austria.ORCID 0000-0002-4665-7433

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The exclusive asialoglycoprotein receptor (ASGR) expression on hepatocytes makes it an attractive target for imaging of the functional liver reserve. Here, we present a set of TRAP-based glycoside trimers and evaluate their imaging properties compared to the gold standard [

Indexed as

Asialoglycoprotein ReceptorGallium RadioisotopesGlycosidesLiverRadiopharmaceuticalsAnimalsHumansMaleMiceTissue DistributionAsialoglycoprotein ReceptorGallium-68Gallium RadioisotopesGlycosidesRadiopharmaceuticals

Identifiers

PMID39413281
PMCPMC11571218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.